MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells

Oncoscience

Volumn 1, Issue 4, 2014, Pages 250-261

  Ninio Many, Lihi ^a   Grossman, Hadas ^a   Levi, Mattan ^a   Zilber, Sofia ^b   Tsarfaty, Ilan ^a   Shomron, Noam ^a   Tuvar, Anna ^b   Chuderland, Dana ^a   Stemmer, Salomon M ^a   Ben Aharon, Irit ^a   Shalgi, Ruth ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Actin cytoskeleton; EMT; Fyn; Live imaging; Migration; MiR 125a 3p; Prostate cancer

Indexed keywords

EID: 84921405487     PISSN: None     EISSN: 23314737     Source Type: Journal    
DOI: 10.18632/oncoscience.29     Document Type: Article

References (42)

1. Parsons SJ and Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene. 2004; 23(48): 7906-7909.
2. Thomas SM and Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997; 13: 513-609.
3. Tang X, Feng Y and Ye K. Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhanceractivating Akt, preventing its apoptotic cleavage and promoting cell survival. Cell Death Differ. 2007; 14(2): 368-377.
4. Prag S, Lepekhin EA, Kolkova K, Hartmann-Petersen R, Kawa A, Walmod PS, Belman V, Gallagher HC, Berezin V, Bock E and Pedersen N. NCAM regulates cell motility. J Cell Sci. 2002; 115(Pt 2): 283-292.
5. Cai H, Smith DA, Memarzadeh S, Lowell CA, Cooper JA and Witte ON. Differential transformation capacity of Src family kinases during the initiation of prostate cancer. Proc Natl Acad Sci U S A. 2011; 108(16): 6579-6584.
6. Kim LC, Song L and Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol. 2009; 6(10): 587-595.
7. Yadav V and Denning MF. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog. 2011; 50(5): 346-352.
8. Kim HJ, Warren JT, Kim SY, Chappel JC, DeSelm CJ, Ross FP, Zou W and Teitelbaum SL. Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells. J Cell Biochem. 2010; 111(5): 1107-1113.
9. Lewin B, Siu A, Baker C, Dang D, Schnitt R, Eisapooran P and Ramos DM. Expression of Fyn kinase modulates EMT in oral cancer cells. Anticancer Res. 2010; 30(7): 2591-2596.
10. Posadas EM, Al-Ahmadie H, Robinson VL, Jagadeeswaran R, Otto K, Kasza KE, Tretiakov M, Siddiqui J, Pienta KJ, Stadler WM, Rinker-Schaeffer C and Salgia R. FYN is overexpressed in human prostate cancer. BJU Int. 2009; 103(2): 171-177.
11. Jensen AR, David SY, Liao C, Dai J, Keller ET, Al-Ahmadie H, Dakin-Hache K, Usatyuk P, Sievert MF, Paner GP, Yala S, Cervantes GM, Natarajan V, Salgia R and Posadas EM. Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells. Clin Cancer Res. 2011; 17(10): 3112-3122.
12. Saito YD, Jensen AR, Salgia R and Posadas EM. Fyn: a novel molecular target in cancer. Cancer. 2010; 116(7): 1629-1637.
13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-297.
14. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7): 2257-2261.
15. Xi JJ. MicroRNAs in Cancer. Cancer Treat Res. 2013; 158: 119-137.
16. Shen J, Stass SA and Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013; 329(2): 125-136.
17. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol. 2010; 42(8): 1273-1281.
18. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS and Benz CC. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 2007; 282(2): 1479-1486.
19. Bi Q, Tang S, Xia L, Du R, Fan R, Gao L, Jin J, Liang S, Chen Z, Xu G, Nie Y, Wu K, Liu J, Shi Y, Ding J and Fan D. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One. 2012; 7(6): e40169.
20. Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res. 2011; 17(9): 2725-2733.
21. Huang B, Luo W, Sun L, Zhang Q, Jiang L, Chang J, Qiu X and Wang E. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells. Int J Oncol. 2013; 42(5): 1734-1742.
22. Ninio-Many L, Grossman H, Shomron N, Chuderland D and Shalgi R. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn. J Cell Sci. 2013; 126(Pt 13): 2867-2876.
23. Turner CE. Paxillin interactions. J Cell Sci. 2000; 113 Pt 23: 4139-4140.
24. Dalmay T and Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene. 2006; 25(46): 6170-6175.
25. Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, Vecchione A, Colombatti A, Friedl P and Baldassarre G. The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol. 2009; 29(18): 5031-5045.
26. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6): 442-454.
27. Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H and Mikulits W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res. 2004; 566(1): 9-20.
28. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y and Johnson KR. Cadherin switching. J Cell Sci. 2008; 121(Pt 6): 727-735.
29. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P and Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem. 2008; 283(10): 6232-6240.
30. Ridley AJ. Life at the leading edge. Cell. 2011; 145(7): 1012-1022.
31. Merajver SD and Usmani SZ. Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia. 2005; 10(4): 291-298.
32. Levi M, Kaplan-Kraicer R and Shalgi R. Regulation of division in mammalian oocytes: implications for polar body formation. Mol Hum Reprod. 2011; 17(5): 328-334.
33. Talmor-Cohen A, Tomashov-Matar R, Tsai WB, Kinsey WH and Shalgi R. Fyn kinase-tubulin interaction during meiosis of rat eggs. Reproduction. 2004; 128(4): 387-393.
34. Chen M, Chen SC and Pallen CJ. Integrin-induced tyrosine phosphorylation of protein-tyrosine phosphatase-alpha is required for cytoskeletal reorganization and cell migration. J Biol Chem. 2006; 281(17): 11972-11980.
35. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R and Kreisberg JI. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res. 2002; 8(4): 1168-1171.
36. Cariaga-Martinez AE, Lopez-Ruiz P, Nombela-Blanco MP, Motino O, Gonzalez-Corpas A, Rodriguez-Ubreva J, Lobo MV, Cortes MA and Colas B. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgenindependent prostate cancer cells. Cell Signal. 2013; 25(7): 1586-1597.
37. Gilhooly EM and Rose DP. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol. 1999; 15(2): 267-270.
38. Roche S. [Tyrosine kinases of the Src family, enzymes with multiple functions: from the growth of fibroblasts to the migration of epithelial cells]. C R Seances Soc Biol Fil. 1998; 192(2): 357-365.
39. Cary LA, Chang JF and Guan JL. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci. 1996; 109 (Pt 7): 1787-1794.
40. Laser-Azogui A, Diamant-Levi T, Israeli S, Roytman Y and Tsarfaty I. Met-induced membrane blebbing leads to amoeboid cell motility and invasion. Oncogene. 2013.
41. Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X and Wang E. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer. 2010; 10: 318.
42. Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y and Mori M. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Int J Oncol. 2012; 40(5): 1477-1482.